WHO recommends long-acting cabotegravir for HIV prevention: New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive approach to HIV prevention. WHO today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention […]
The first long-acting option to protect women from HIV, proven to reduce women’s HIV risk, has been recommended for use by the World Health Organization (WHO). For nearly two decades, researchers from the School of Pharmacy at Queen’s University Belfast have been supporting development of a new drug-releasing vaginal ring to protect women from infection […]
HIV treatments – where we are today and what’s next: Despite the ambitious 2020 goals set by UNAIDS 90-90-90 not being reached, innovative HIV treatments – from preventative to curative – are just around the corner and key to the success in eradicating the HIV epidemic that has killed more than 39 million people worldwide. In a new […]
To mark World Aids Day (1st December 2018), Marc Thompson of the Terrence Higgins Trust talks about progress on reducing new cases of HIV in the UK. ‘We have come a long way to achieving our aspiration of getting down to zero new cases of HIV in the UK although we haven’t got there yet. […]
Everyone who was there, and many people who followed the Hippocratic Post 2018, The end of HIV debate, on Twitter and social media, agreed that last week’s event was a powerful and compelling discussion about one of the most important health issues of our time. Over 70 invited guests gathered in the historic Apothecaries Hall […]